Crossmark

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

Published Online: 2020-10-16

Published Print: 2021-01

Authors

Chandra, Sharat https://orcid.org/0000-0002-2933-814X
Chandrakasan, Shanmuganathan

Dávila Saldaña, Blachy J.

Bleesing, Jack J.

Jordan, Michael B.

Kumar, Ashish R.

Grimley, Michael S.

Krupski, Christa

Davies, Stella M.

Khandelwal, Pooja

Marsh, Rebecca A.
License Information

Text and Data Mining valid from 2020-10-16

Version of Record valid from 2020-10-16
More Information

Article History

Received: 30 July 2020

Accepted: 4 October 2020

First Online: 16 October 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflicts of interest.

Document is current